dan 2163 has been researched along with lithium carbonate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danileviciūte, V | 1 |
| Been, G; Garg, V; Magoulas, P; Yasugi, S | 1 |
1 review(s) available for dan 2163 and lithium carbonate
| Article | Year |
|---|---|
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
1 other study(ies) available for dan 2163 and lithium carbonate
| Article | Year |
|---|---|
Neuroleptic malignant syndrome.
Topics: Adult; Amisulpride; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Neuroleptic Malignant Syndrome; Recurrence; Risk Factors; Sulpiride | 2010 |